Organism name | Rhodobacter capsulatus |
---|---|
Genus | Rhodobacter |
Family | Rhodobacteraceae |
Kingdom |
Linked NCBI taxonomy name | Rhodobacter capsulatus |
---|---|
Linked NCBI taxonomy ID | 1061 |
Linked level | species |
Family in NCBI taxonomy | Rhodobacteraceae |
---|---|
ID | 31989 |
Kingdom (Superkingdom) in NCBI taxonomy | Bacteria |
---|---|
ID | 2 |
Plant class | |
---|---|
ID |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00000913
![]() |
Phytofluene
|
No. 97 | No. 59 |
![]() |
||||
C00000930
![]() |
Spheroidene
|
C005637
|
No. 97 | No. 59 |
![]() |
|||
C00000906
![]() |
7,8,11,12-Tetrahydrolycopene
|
No. 97 | No. 59 |
![]() |
||||
C00000928
![]() |
Methoxyneurosporene
/ 3,4-Dihydrospheroidene |
No. 97 | No. 59 |
![]() |
||||
C00000927
![]() |
Chloroxanthin
/ Hydroxyneurosporene |
No. 97 | No. 59 |
![]() |
||||
C00000924
![]() |
Demethylspheroidenone
|
No. 97 | No. 59 |
![]() |
||||
C00000911
![]() |
Lycopene
/ all-trans-Lycopene |
CHEMBL501174
CHEMBL1984187 |
C015329
|
6 / 13 / 13 | 84 / 13 | No. 97 | No. 59 |
![]() |
C00000912
![]() |
Neurosporene
|
C008604
|
No. 97 | No. 59 |
![]() |
|||
C00000923
![]() |
Demethylspheroidene
|
No. 97 | No. 59 |
![]() |
||||
C00000914
![]() |
Spheroidenone
|
C104880
|
No. 97 | No. 59 |
![]() |
|||
C00022964
![]() |
Rhodobacterioxanthin
/ (E)-1,1'-Dimethoxy-3,4,3',4'-tetradehydro-1,2,1',2'-tetrahydro-psi,psi-catoten-20-al |
No. 402 |
![]() |
|||||
C00000905
![]() |
Phytoene
/ 15-cis-Phytoene / 15,15'-cis-Phytoene |
CHEMBL1988265
|
No. 2614 | No. 59 |
![]() |
|||
C00000846
![]() |
Geranyl diphosphate
/ Geranyl pyrophosphate |
CHEMBL41342
|
C015234
|
1 / 0 / 0 | 2 / 0 | No. 3475 | No. 34 |
![]() |
C00000907
![]() |
FPP
/ Farnesyl pyrophosphate |
CHEMBL69330
CHEMBL1160056 CHEMBL1160060 |
C004808
|
5 / 0 / 0 | 11 / 1 | No. 4178 | No. 38 |
![]() |
C00000908
![]() |
GGPP
/ Geranylgeranyl diphosphate / Geranylgeranyl pyrophosphate |
CHEMBL1160059
CHEMBL1160061 CHEMBL1229266 |
C002963
|
3 / 0 / 0 | 34 / 0 | No. 4178 | No. 38 |
![]() |
C00007561
![]() |
2-Phosphoglycolate
|
CHEMBL47181
|
No. 6323 |
![]() |
||||
C00000910
![]() |
Isopentenyl phosphate
|
CHEMBL342070
|
No. 8436 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P53609 | Geranylgeranyl transferase type-1 subunit beta | Enzyme | C00000907 C00000908 | 0 / 0 |
P49354 | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Enzyme | C00000907 C00000908 | 0 / 0 |
P49356 | Protein farnesyltransferase subunit beta | Enzyme | C00000907 C00000908 | 0 / 0 |
P14324 | Farnesyl pyrophosphate synthase | Transferase | C00000846 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00000911 | 0 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00000911 | 0 / 0 |
P11473 | Vitamin D3 receptor | NR1I1 | C00000911 | 2 / 3 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00000911 | 0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00000911 | 0 / 0 |
O95749 | Geranylgeranyl pyrophosphate synthase | Enzyme | C00000907 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00000911 | 11 / 10 |
P37268 | Squalene synthase | Enzyme | C00000907 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
6401 | SELE, CD62E, ELAM, ELAM1, ESEL, LECAM2 | selectin E |
C00000907
C00000908
C00000911
|
3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00000907
C00000908
C00000911
|
3156 | HMGCR, LDLCQ3 | 3-hydroxy-3-methylglutaryl-CoA reductase (EC:1.1.1.34) |
C00000846
C00000907
C00000908
|
387 | RHOA, ARH12, ARHA, RHO12, RHOH12 | ras homolog family member A |
C00000907
C00000908
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00000908
C00000911
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00000908
C00000911
|
207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00000908
C00000911
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00000907
C00000908
|
5879 | RAC1, Rac-1, TC-25, p21-Rac1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
C00000907
C00000908
|
5444 | PON1, ESA, MVCD5, PON | paraoxonase 1 (EC:3.1.1.2 3.1.8.1 3.1.1.81) |
C00000907
C00000908
|
332 | BIRC5, API4, EPR-1 | baculoviral IAP repeat containing 5 |
C00000907
C00000908
|
3265 | HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1 | Harvey rat sarcoma viral oncogene homolog |
C00000907
C00000908
|
2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog |
C00000907
C00000911
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00000908
C00000911
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00000907
C00000908
|
100507436 | MICA, MIC-A, PERB11.1 | MHC class I polypeptide-related sequence A |
C00000911
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00000908
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00000908
|
3552 | IL1A, IL-1A, IL1, IL1-ALPHA, IL1F1 | interleukin 1, alpha |
C00000908
|
4312 | MMP1, CLG, CLGN | matrix metallopeptidase 1 (interstitial collagenase) (EC:3.4.24.7) |
C00000908
|
4318 | MMP9, CLG4B, GELB, MANDP2, MMP-9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) |
C00000908
|
4792 | NFKBIA, IKBA, MAD-3, NFKBI | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
C00000908
|
8013 | NR4A3, CHN, CSMF, MINOR, NOR1, TEC | nuclear receptor subfamily 4, group A, member 3 |
C00000908
|
142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00000908
|
5155 | PDGFB, IBGC5, PDGF-2, PDGF2, SIS, SSV, c-sis | platelet-derived growth factor beta polypeptide |
C00000908
|
9453 | GGPS1, GGPPS, GGPPS1 | geranylgeranyl diphosphate synthase 1 (EC:2.5.1.1 2.5.1.10 2.5.1.29) |
C00000908
|
2152 | F3, CD142, TF, TFA | coagulation factor III (thromboplastin, tissue factor) |
C00000908
|
56729 | RETN, ADSF, FIZZ3, RETN1, RSTN, XCP1 | resistin |
C00000908
|
1490 | CTGF, CCN2, HCS24, IGFBP8, NOV2 | connective tissue growth factor |
C00000908
|
1401 | CRP, PTX1 | C-reactive protein, pentraxin-related |
C00000908
|
7040 | TGFB1, CED, DPD1, LAP, TGFB, TGFbeta | transforming growth factor, beta 1 |
C00000908
|
1277 | COL1A1, OI4 | collagen, type I, alpha 1 |
C00000908
|
8743 | TNFSF10, APO2L, Apo-2L, CD253, TL2, TRAIL | tumor necrosis factor (ligand) superfamily, member 10 |
C00000908
|
7422 | VEGFA, MVCD1, VEGF, VPF | vascular endothelial growth factor A |
C00000908
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00000908
|
5906 | RAP1A, KREV-1, KREV1, RAP1, SMGP21 | RAP1A, member of RAS oncogene family |
C00000846
|
118 | ADD1, ADDA | adducin 1 (alpha) |
C00000911
|
177 | AGER, RAGE | advanced glycosylation end product-specific receptor |
C00000911
|
196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00000911
|
367 | AR, AIS, DHTR, HUMARA, HYSP1, KD, NR3C4, SBMA, SMAX1, TFM | androgen receptor |
C00000911
|
571 | BACH1, BACH-1 | BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
C00000911
|
8314 | BAP1, HUCEP-13, UCHL2 | BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) (EC:3.4.19.12) |
C00000911
|
673 | BRAF, B-RAF1, BRAF1, NS7, RAFB1 | v-raf murine sarcoma viral oncogene homolog B (EC:2.7.11.1) |
C00000911
|
841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00000911
|
847 | CAT | catalase (EC:1.11.1.6) |
C00000911
|
595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00000911
|
898 | CCNE1, CCNE | cyclin E1 |
C00000911
|
983 | CDK1, CDC2, CDC28A, P34CDC2 | cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22) |
C00000911
|
1019 | CDK4, CMM3, PSK-J3 | cyclin-dependent kinase 4 (EC:2.7.11.22) |
C00000911
|
1020 | CDK5, PSSALRE | cyclin-dependent kinase 5 (EC:2.7.11.22) |
C00000911
|
1022 | CDK7, CAK1, CDKN7, HCAK, MO15, STK1, p39MO15 | cyclin-dependent kinase 7 (EC:2.7.11.23 2.7.11.22) |
C00000911
|
1025 | CDK9, C-2k, CDC2L4, CTK1, PITALRE, TAK | cyclin-dependent kinase 9 (EC:2.7.11.23 2.7.11.22) |
C00000911
|
1113 | CHGA, CGA | chromogranin A (parathyroid secretory protein 1) |
C00000911
|
1114 | CHGB, SCG1 | chromogranin B (secretogranin 1) |
C00000911
|
23418 | CRB1, LCA8, RP12 | crumbs homolog 1 (Drosophila) |
C00000911
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00000911
|
1643 | DDB2, DDBB, UV-DDB2 | damage-specific DNA binding protein 2, 48kDa |
C00000911
|
1981 | EIF4G1, EIF-4G1, EIF4F, EIF4G, EIF4GI, P220, PARK18 | eukaryotic translation initiation factor 4 gamma, 1 |
C00000911
|
2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00000911
|
2100 | ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2 | estrogen receptor 2 (ER beta) |
C00000911
|
2176 | FANCC, FA3, FAC, FACC | Fanconi anemia, complementation group C |
C00000911
|
2188 | FANCF, FAF | Fanconi anemia, complementation group F |
C00000911
|
356 | FASLG, ALPS1B, APT1LG1, APTL, CD178, CD95-L, CD95L, FASL, TNFSF6 | Fas ligand (TNF superfamily, member 6) |
C00000911
|
2701 | GJA4, CX37 | gap junction protein, alpha 4, 37kDa |
C00000911
|
2702 | GJA5, ATFB11, CX40 | gap junction protein, alpha 5, 40kDa |
C00000911
|
2879 | GPX4, GPx-4, GSHPx-4, MCSP, PHGPx, snGPx, snPHGPx | glutathione peroxidase 4 (EC:1.11.1.12) |
C00000911
|
3146 | HMGB1, HMG1, HMG3, SBP-1 | high mobility group box 1 |
C00000911
|
3479 | IGF1, IGF-I, IGF1A, IGFI | insulin-like growth factor 1 (somatomedin C) |
C00000911
|
3480 | IGF1R, CD221, IGFIR, IGFR, JTK13 | insulin-like growth factor 1 receptor (EC:2.7.10.1) |
C00000911
|
3485 | IGFBP2, IBP2, IGF-BP53 | insulin-like growth factor binding protein 2, 36kDa |
C00000911
|
3713 | IVL | involucrin |
C00000911
|
3716 | JAK1, JAK1A, JAK1B, JTK3 | Janus kinase 1 (EC:2.7.10.2) |
C00000911
|
3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00000911
|
3796 | KIF2A, CDCBM3, HK2, KIF2 | kinesin heavy chain member 2A |
C00000911
|
3838 | KPNA2, IPOA1, QIP2, RCH1, SRP1alpha | karyopherin alpha 2 (RAG cohort 1, importin alpha 1) |
C00000911
|
3949 | LDLR, FH, FHC, LDLCQ2 | low density lipoprotein receptor |
C00000911
|
3988 | LIPA, CESD, LAL | lipase A, lysosomal acid, cholesterol esterase (EC:3.1.1.13) |
C00000911
|
5604 | MAP2K1, CFC3, MAPKK1, MEK1, MKK1, PRKMK1 | mitogen-activated protein kinase kinase 1 (EC:2.7.12.2) |
C00000911
|
5605 | MAP2K2, CFC4, MAPKK2, MEK2, MKK2, PRKMK2 | mitogen-activated protein kinase kinase 2 (EC:2.7.12.2) |
C00000911
|
6416 | MAP2K4, JNKK, JNKK1, MAPKK4, MEK4, MKK4, PRKMK4, SAPKK-1, SAPKK1, SEK1, SERK1, SKK1 | mitogen-activated protein kinase kinase 4 (EC:2.7.12.2) |
C00000911
|
5608 | MAP2K6, MAPKK6, MEK6, MKK6, PRKMK6, SAPKK-3, SAPKK3 | mitogen-activated protein kinase kinase 6 (EC:2.7.12.2) |
C00000911
|
1432 | MAPK14, CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA | mitogen-activated protein kinase 14 (EC:2.7.11.24) |
C00000911
|
5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) |
C00000911
|
4247 | MGAT2, CDG2A, CDGS2, GLCNACTII, GNT-II, GNT2 | mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase (EC:2.4.1.143) |
C00000911
|
3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00000908
|
4292 | MLH1, COCA2, FCC2, HNPCC, HNPCC2, hMLH1 | mutL homolog 1 |
C00000911
|
4436 | MSH2, COCA1, FCC1, HNPCC, HNPCC1, LCFS2 | mutS homolog 2 |
C00000911
|
2956 | MSH6, GTBP, GTMBP, HNPCC5, HSAP, p160 | mutS homolog 6 |
C00000911
|
4842 | NOS1, IHPS1, N-NOS, NC-NOS, NOS, bNOS, nNOS | nitric oxide synthase 1 (neuronal) (EC:1.14.13.39) |
C00000911
|
8021 | NUP214, CAIN, CAN, D9S46E, N214, p250 | nucleoporin 214kDa |
C00000911
|
5320 | PLA2G2A, MOM1, PLA2, PLA2B, PLA2L, PLA2S, PLAS1, sPLA2 | phospholipase A2, group IIA (platelets, synovial fluid) (EC:3.1.1.4) |
C00000911
|
5591 | PRKDC, DNA-PKcs, DNAPK, DNPK1, HYRC, HYRC1, XRCC7, p350 | protein kinase, DNA-activated, catalytic polypeptide (EC:2.7.11.1) |
C00000911
|
10111 | RAD50, NBSLD, RAD502, hRad50 | RAD50 homolog (S. cerevisiae) |
C00000911
|
8045 | RASSF7, C11orf13, HRAS1, HRC1 | Ras association (RalGDS/AF-6) domain family (N-terminal) member 7 |
C00000911
|
5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 |
C00000911
|
5962 | RDX, DFNB24 | radixin |
C00000911
|
6195 | RPS6KA1, HU-1, MAPKAPK1A, RSK, RSK1 | ribosomal protein S6 kinase, 90kDa, polypeptide 1 (EC:2.7.11.1) |
C00000911
|
6197 | RPS6KA3, CLS, HU-3, ISPK-1, MAPKAPK1B, MRX19, RSK, RSK2, S6K-alpha3, p90-RSK2, pp90RSK2 | ribosomal protein S6 kinase, 90kDa, polypeptide 3 (EC:2.7.11.1) |
C00000911
|
6241 | RRM2, R2, RR2, RR2M | ribonucleotide reductase M2 (EC:1.17.4.1) |
C00000911
|
6414 | SEPP1, SELP, SeP | selenoprotein P, plasma, 1 |
C00000911
|
4088 | SMAD3, HSPC193, HsT17436, JV15-2, LDS1C, LDS3, MADH3 | SMAD family member 3 |
C00000911
|
8243 | SMC1A, CDLS2, DXS423E, SB1.8, SMC1, SMC1L1, SMC1alpha, SMCB | structural maintenance of chromosomes 1A |
C00000911
|
6774 | STAT3, APRF, HIES | signal transducer and activator of transcription 3 (acute-phase response factor) |
C00000911
|
7031 | TFF1, BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2 | trefoil factor 1 |
C00000911
|
7980 | TFPI2, PP5, REF1, TFPI-2 | tissue factor pathway inhibitor 2 |
C00000911
|
7039 | TGFA, TFGA | transforming growth factor, alpha |
C00000911
|
7097 | TLR2, CD282, TIL4 | toll-like receptor 2 |
C00000911
|
7099 | TLR4, ARMD10, CD284, TLR-4, TOLL | toll-like receptor 4 |
C00000911
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00000911
|
7412 | VCAM1, CD106, INCAM-100 | vascular cell adhesion molecule 1 |
C00000911
|
7415 | VCP, ALS14, IBMPFD, IBMPFD1, TERA, p97 | valosin containing protein (EC:3.6.4.6) |
C00000911
|
7485 | WRB, CHD5 | tryptophan rich basic protein |
C00000911
|
7697 | ZNF138, pHZ-32 | zinc finger protein 138 |
C00000911
|
OMIM | preferred title | UniProt |
---|---|---|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
KEGG | name | UniProt |
---|---|---|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D010146 | Pain |
C00000907
|
D056486 | Drug-Induced Liver Injury |
C00000911
|
D006943 | Hyperglycemia |
C00000911
|
D006965 | Hyperplasia |
C00000911
|
D007248 | Infertility, Male |
C00000911
|
D007249 | Inflammation |
C00000911
|
D007674 | Kidney Diseases |
C00000911
|
D009369 | Neoplasms |
C00000911
|
D020258 | Neurotoxicity Syndromes |
C00000911
|
D011471 | Prostatic Neoplasms |
C00000911
|
D012878 | Skin Neoplasms |
C00000911
|
D013733 | Testicular Diseases |
C00000911
|
D014178 | Translocation, Genetic |
C00000911
|
D015431 | Weight Loss |
C00000911
|